sb 203580 has been researched along with PDGF receptor tyrosine kinase inhibitor III in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (PDGF receptor tyrosine kinase inhibitor III) | Trials (PDGF receptor tyrosine kinase inhibitor III) | Recent Studies (post-2010) (PDGF receptor tyrosine kinase inhibitor III) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 5 | 0 | 1 |
| Protein | Taxonomy | sb 203580 (IC50) | PDGF receptor tyrosine kinase inhibitor III (IC50) |
|---|---|---|---|
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.0925 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.05 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.065 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
1 other study(ies) available for sb 203580 and PDGF receptor tyrosine kinase inhibitor III
| Article | Year |
|---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |